• Advocate Health Building Clinical Trial Capacity Systemwide

    Oct 22 | Clinical Research News | Advocate Health, one of the largest health systems in the U.S., is extending its “care for all” mission to clinical research with the building of an organization-wide National Center for Clinical Trials (NCCT) focused on supporting and accelerating industry-funded studies. The initiative launched last November and encompasses 69 hospitals and over 1,000 care sites across eight states, collectively serving nearly 6 million patients, according to NCCT President Adam Samson. More

  • Feasibility Simulator Wins Best of Show Award in Spain

    Oct 20 | Clinical Research News | Medidata's Study Feasibility Scenario Simulator was named the 2026 Best of Show Award winner at SCOPE Europe last week, chosen from among 20 new products on display at the European event. More

  • A Vision for Connecting Better Care with Better Clinical Trial Design

    Oct 19 | Clinical Research News | The latest episode of the Scope of Things podcast shares a conversation between Michelle Snyder of McKesson and Synapticure CEO Sandra Abravaya as they follow Abravaya’s path from public service to healthcare entrepreneurship, grounded in an ALS caregiver’s view of what happens when guidance is unavailable at the moment it matters most. More

  • The Evolution of RBQM: From Regulatory Compliance to Proven ROI and Data Quality

    Oct 19 | Clinical Research News | Today, RBQM offers not just regulatory compliance but the ability to add measurable value to drug development and sponsor organizations. However, many organizations are still operating with fragmented tools, static risk registers and reactive monitoring models. To unlock the true power of RBQM, the industry needs to embrace its potential as a live, operational oversight model. More

  • Lab-Grown Brain Models Could Bring ‘Clinical Trials in a Vial,’ Harvard Researcher Says

    Oct 19 | Clinical Research News | Brain organoids, three-dimensional tissues grown from stem cells, are edging closer to the clinic, with researchers envisioning a future in which a patient's response to a drug can be tested in a lab dish before they ever enroll in a study. More

  • Medzown Tackling Flaws in Clinical Trial Enrollment Ecosystem

    Oct 15 | Clinical Research News | A startup precision medicine management company is “cracking the code” on how to make cutting-edge treatments more accessible to patients and at the same time financially sustainable for all stakeholders. The approach of 3-year-old Medzown collapses the boundaries between clinical care and clinical trials to create a unified care pathway, according to founder and CEO Jennifer Levin Carter, M.D. More

  • A Vision for Connecting Better Care with Better Clinical Trial Design

    Oct 13 | Clinical Research News | The latest episode of the Scope of Things podcast shares a conversation between Michelle Snyder of McKesson and Synapticure CEO Sandra Abravaya as they follow Abravaya’s path from public service to healthcare entrepreneurship, grounded in an ALS caregiver’s view of what happens when guidance is unavailable at the moment it matters most. More

  • Lab-Grown Brain Models Could Bring ‘Clinical Trials in a Vial,’ Harvard Researcher Says

    Oct 08 | Clinical Research NewsBrain organoids, three-dimensional tissues grown from stem cells, are edging closer to the clinic, with researchers envisioning a future in which a patient's response to a drug can be tested in a lab dish before they ever enroll in a study. More

  • The Evolution of RBQM: From Regulatory Compliance to Proven ROI and Data Quality

    Oct 06 | Clinical Research NewsToday, RBQM offers not just regulatory compliance but the ability to add measurable value to drug development and sponsor organizations. However, many organizations are still operating with fragmented tools, static risk registers and reactive monitoring models. To unlock the true power of RBQM, the industry needs to embrace its potential as a live, operational oversight model. More

  • Follow the Money: Phase 3 Thyroid Eye Disease, Pivotal Dravet Syndrome Gene Therapy, Pediatric Brain Cancer CAR T

    Oct 01 | Clinical Research News | Funding news from around the biotech space including investments in Phase 2 sepsis, leukemia peptide immunotherapy, colon cancer, Phase 1 obesity, atherosclerosis, more. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

Read More